home / stock / crsp / crsp articles

CRSP Articles, CRISPR Therapeutics AG - From 01/03/24

Stock Information
Company Name: CRISPR Therapeutics AG
Stock Symbol: CRSP
Market: NASDAQ
Website: crisprtx.com
Menu
CRSP CRSP Quote CRSP Short CRSP News CRSP Articles CRSP Message Board
Get CRSP Alerts

News, Short Squeeze, Breakout and More Instantly...
CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

ZUG, Switzerland and BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creatin...
Here's How Much $100 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today | Benzinga

CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 2.15% on an annualized basis producing an average annual ret...

Cathie Wood's Ark Invest Sells Nearly $11.5M Worth Of Coinbase Shares As Bitcoin, Crypto Rally Loses Steam | Benzinga

Cathie Wood-led Ark Invest made a notable move in the market by selling a significant portion of its Coinbase Global Inc (NASDAQ:COIN) shares on Tu...

HP To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Monday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
FDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood Disorder | Benzinga

The FDA has approved Casgevy and Lyfgenia, representing the first cell-based gene therapies for sickle cell disease in patients 12 years ...

Here's How Much $1000 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today | Benzinga

CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 3.11% on an annualized basis producing an average annual ret...

CRISPR Therapeutics' Gene-Edited Oncology Pipeline To Focus On Expanded Use In Autoimmune Diseases | Benzinga

Monday, CRISPR Therapeutics AG (NASDAQ: CRSP) provided an update on its immuno-oncology pipeline of CRISPR/Cas9 gene-edited allogeneic ch...
Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback' | Benzinga

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he would not buy CRISPR Therapeutics AG (NASDAQ: CRSP) stock "all the...

What's Going On With Crispr Therapeutics Stock Monday? | Benzinga

CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Monday on what appears to be continued momentum from the recent regulatory aut...

Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday. Shares of Ross Stores, Inc. (NASDAQ: ROST) surged during Frid...
Previous 10 Next 10